Atai Life Sciences (NASDAQ:ATAI) announced promising preliminary results on Tuesday for its DMT-based depression therapy ... Johnson's ketamine-based depression drug, Spravato.
So Small Pharma has focused on another psychedelic drug, DMT. This is one of the active ingredients of the traditional Amazonian herbal medicine ayahuasca and it is also found endogenously in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果